X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-13 | ACRV | Acrivon Therapeutics, Inc. | Devroe Eric | COO | P - Purchase | $1.72 | +10,000 | 75,308 | +15% | +$17,218 | ||||||
2026-01-14 | ACRV | Acrivon Therapeutics, Inc. | Levy Adam D. | CFO | P - Purchase | $1.70 | +8,832 | 20,983 | +73% | +$14,999 | ||||||
2026-01-14 | ACRV | Acrivon Therapeutics, Inc. | Blume-Jensen Peter | Pres, CEO | P - Purchase | $1.68 | +49,000 | 2,410,477 | +2% | +$82,124 | ||||||
2026-01-15 | AIRJ | Airjoule Technologies Corp. | Jore Matthew B | CEO, 10% | P - Purchase | $3.25 | +7,692 | 7,718,123 | 0% | +$24,999 | ||||||
2026-01-15 | AIRJ | Airjoule Technologies Corp. | Eilers Patrick C | Exec COB | P - Purchase | $3.25 | +76,923 | 4,593,750 | +2% | +$250,000 | ||||||
2026-01-15 | AIRJ | Airjoule Technologies Corp. | Porter Stuart D | Dir, 10% | P - Purchase | $3.25 | +153,846 | 19,532,653 | +1% | +$500,000 | ||||||
2026-01-15 | AKAN | Akanda Corp. | Hrt Financial LP | 10% | P - Purchase | $1.40 | +29,036 | 7,816 | -137% | +$40,650 | ||||||
2026-02-02 | ALXO | Alx Oncology Holdings Inc | Goodman Corey S | Dir, 10% | P - Purchase | $1.57 | +3,184,713 | 13,052,008 | +32% | +$4,999,999 | ||||||
2026-01-28 | ANIX | Anixa Biosciences Inc | Baskies Arnold M | Dir | P - Purchase | $3.04 | +10,000 | 135,000 | +8% | +$30,400 | ||||||
| D | 2026-01-30 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO | P - Purchase | $0.89 | +28,100 | 375,520 | +8% | +$25,009 | |||||
2026-01-13 | ASST | Strive, Inc. | Cole Matthew Ryan | CEO | P - Purchase | $0.92 | +500,000 | 1,200,380 | +71% | +$459,350 | ||||||
2026-01-12 | BUKS | Butler National Corp | Loh Michael Anthony | Dir | P - Purchase | $2.87 | +8,000 | 134,342 | +6% | +$22,956 | ||||||
2026-01-21 | CABA | Cabaletta Bio, Inc. | Tomasello Shawn | Dir | P - Purchase | $2.21 | +22,725 | 22,725 | New | +$50,322 | ||||||
2026-01-21 | CABA | Cabaletta Bio, Inc. | Chang David J. | Chief Medical Officer | P - Purchase | $2.26 | +8,800 | 8,800 | New | +$19,888 | ||||||
2026-01-21 | CABA | Cabaletta Bio, Inc. | Binder Gwendolyn | Pres, Science, Tech. | P - Purchase | $2.19 | +11,312 | 31,312 | +57% | +$24,763 | ||||||
2026-01-21 | CABA | Cabaletta Bio, Inc. | Gavel Steve | CHIEF COMMERCIAL OFFICER | P - Purchase | $2.27 | +22,170 | 22,170 | New | +$50,215 | ||||||
2026-01-21 | CABA | Cabaletta Bio, Inc. | Simon Mark | Dir | P - Purchase | $2.28 | +11,061 | 154,205 | +8% | +$25,261 | ||||||
2026-01-21 | CABA | Cabaletta Bio, Inc. | Nichtberger Steven | Pres, CEO | P - Purchase | $2.24 | +45,000 | 1,394,483 | +3% | +$100,778 | ||||||
2026-01-21 | CABA | Cabaletta Bio, Inc. | Gerard Michael | GC | P - Purchase | $2.27 | +6,600 | 6,600 | New | +$14,979 | ||||||
2026-02-06 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $0.95 | +50,000 | 1,915,651 | +3% | +$47,280 | ||||||
2026-01-12 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.50 | +113,185 | 7,244,979 | +2% | +$57,000 | ||||||
2026-01-23 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.50 | +90,325 | 8,182,120 | +1% | +$45,000 | ||||||
2026-01-20 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.50 | +353,321 | 8,091,795 | +5% | +$175,000 | ||||||
2026-01-14 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.45 | +493,495 | 7,738,474 | +7% | +$220,000 | ||||||
| M | 2026-01-28 | ELUT | Elutia Inc. | Neels Guido J | Dir | P - Purchase | $1.06 | +30,000 | 98,750 | +44% | +$31,800 | |||||
2026-01-30 | ELUT | Elutia Inc. | Rakin Kevin | Dir, 10% | P - Purchase | $1.06 | +70,000 | 5,225,098 | +1% | +$74,200 | ||||||
2026-01-30 | ELUT | Elutia Inc. | Neels Guido J | Dir | P - Purchase | $1.04 | +20,000 | 118,750 | +20% | +$20,800 | ||||||
| M | 2026-02-02 | EMPD | Empery Digital Inc. | Atg Capital Opportunities Fund LP | 10% | P - Purchase | $4.68 | +691,145 | 4,500,000 | +18% | +$3,232,479 | |||||
| M | 2026-01-28 | EMPD | Empery Digital Inc. | Atg Capital Opportunities Fund LP | 10% | P - Purchase | $4.94 | +428,626 | 3,808,855 | +13% | +$2,115,728 | |||||
2026-02-10 | ENTX | Entera Bio Ltd. | Taitel Haya | Dir | P - Purchase | $1.48 | +7,500 | 0 | -100% | +$11,100 | ||||||
2026-02-10 | ENTX | Entera Bio Ltd. | Germano Geno J | Dir | P - Purchase | $1.49 | +20,000 | 0 | -100% | +$29,800 | ||||||
2026-02-09 | ENTX | Entera Bio Ltd. | Rubin Steven D | Dir | P - Purchase | $1.20 | +10,000 | 10,000 | New | +$12,000 | ||||||
2026-02-09 | ENTX | Entera Bio Ltd. | Ellis Sean | Dir | P - Purchase | $1.24 | +18,000 | 178,098 | +11% | +$22,320 | ||||||
2026-02-02 | FEAM | 5E Advanced Materials, Inc. | Bep Special Situations IV LLC | Dir, 10% | P - Purchase | $2.00 | +4,000,000 | 12,130,997 | +49% | +$8,000,000 | ||||||
| D | 2025-12-18 | GBCS | Selectis Health, Inc. | Baller Lance | Dir, 10% | P - Purchase | $2.20 | +6,192 | 294,374 | +2% | +$13,622 | |||||
2026-01-15 | IMRX | Immuneering Corp | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | P - Purchase | $4.57 | +2,298 | 376,496 | +1% | +$10,502 | ||||||
2026-01-12 | IMRX | Immuneering Corp | Feinberg Peter | Dir | P - Purchase | $4.35 | +20,000 | 1,161,064 | +2% | +$86,904 | ||||||
2026-01-16 | IMRX | Immuneering Corp | Brakewood Harold Eugene | Chief Business Officer | P - Purchase | $4.76 | +5,250 | 11,050 | +91% | +$24,990 | ||||||
2026-01-15 | IMRX | Immuneering Corp | Schall Thomas J. | Dir | P - Purchase | $4.67 | +21,645 | 74,530 | +41% | +$101,041 | ||||||
2026-01-13 | IMRX | Immuneering Corp | Neufeld Leah R | CHIEF PEOPLE OFFICER | P - Purchase | $4.15 | +2,626 | 25,970 | +11% | +$10,906 | ||||||
2026-01-06 | IVFH | Innovative Food Holdings Inc | Schubert Gary | CEO | P - Purchase | $0.30 | +166,666 | 532,569 | +46% | +$50,000 | ||||||
2026-02-05 | LEE | Lee Enterprises, Inc | Quint Digital Ltd | 10% | P - Purchase | $3.25 | +2,451,346 | 3,214,346 | +321% | +$7,966,875 | ||||||
2026-02-09 | LSAK | Lesaka Technologies Inc | Mazanderani Ali | Exec COB | P - Purchase | $4.36 | +91,423 | 2,416,538 | +4% | +$398,604 | ||||||
2026-02-02 | LXRX | Lexicon Pharmaceuticals, Inc. | Invus Global Management, LLC | Dir, 10% | P - Purchase | $1.30 | +1,538,462 | 44,145,189 | +4% | +$2,000,001 | ||||||
2026-01-16 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% | P - Purchase | $4.68 | +140,000 | 1,485,297 | +10% | +$655,200 | ||||||
2026-01-26 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% | P - Purchase | $4.84 | +60,000 | 1,545,297 | +4% | +$290,400 | ||||||
2026-01-28 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% | P - Purchase | $4.57 | +42,100 | 87,397 | +93% | +$192,502 | ||||||
2026-01-16 | ONCY | Oncolytics Biotech Inc | Seizinger Bernd R. | Dir | P - Purchase | $1.04 | +100,000 | 466,991 | +27% | +$103,770 | ||||||
2026-01-16 | OTH | Off the Hook Ys Inc. | Gonnelli Robert Rosario | Dir | P - Purchase | $2.60 | +5,000 | 162,000 | +3% | +$13,000 | ||||||
2026-01-16 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Geygan Jeffrey Richart | Interim CEO, 10% | P - Purchase | $1.98 | +11,300 | 1,977,519 | +1% | +$22,353 | ||||||
2026-01-16 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Global Value Investment Corp. | 10% | P - Purchase | $1.98 | +11,300 | 1,977,519 | +1% | +$22,353 | ||||||
| M | 2026-02-04 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $1.81 | +8,569 | 1,201,824 | +1% | +$15,480 | |||||
| M | 2026-01-30 | SNES | Senestech, Inc. | Glenbrook Capital Management | 10% | P - Purchase | $1.96 | +48,138 | 1,144,831 | +4% | +$94,524 | |||||
2026-02-04 | STEX | Streamex Corp. | Giustra Frank | 10% | P - Purchase | $3.17 | +100,000 | 1,278,205 | +8% | +$317,000 | ||||||
2026-01-27 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir, 10% | P - Purchase | $3.12 | +5,500 | 76,500 | +8% | +$17,160 | ||||||
2026-02-03 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir, 10% | P - Purchase | $3.06 | +23,500 | 102,500 | +30% | +$71,910 | ||||||
2026-01-23 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir | P - Purchase | $3.13 | +41,000 | 48,000 | +586% | +$128,486 | ||||||
2026-01-23 | STEX | Streamex Corp. | Williams Mitchell Young | Chief Investment Officer | P - Purchase | $3.03 | +51,511 | 1,051,511 | +5% | +$155,852 | ||||||
2026-01-23 | STEX | Streamex Corp. | Giustra Frank | 10% | P - Purchase | $3.00 | +1,000,000 | 1,178,205 | +561% | +$3,000,000 | ||||||
2026-01-26 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir, 10% | P - Purchase | $3.30 | +23,000 | 71,000 | +48% | +$75,900 | ||||||
| AD | 2026-02-04 | STQN | Strategic Acquisitions Inc /Nv/ | Oshea John P | Pres, 10% | P - Purchase | $0.00 | +30,000,000 | 30,151,800 | >999% | +$30,000 | |||||
| M | 2026-01-28 | THM | International Tower Hill Mines Ltd | Paulson & Co. Inc. | 10% | P - Purchase | $2.22 | +11,315,632 | 99,573,038 | +13% | +$25,120,703 | |||||
2026-01-27 | THM | International Tower Hill Mines Ltd | Electrum Global Holdings L.P. | 10% | P - Purchase | $2.22 | +3,153,153 | 31,918,825 | +11% | +$7,000,000 | ||||||
2026-01-27 | THM | International Tower Hill Mines Ltd | Paulson & Co. Inc. | 10% | P - Purchase | $2.22 | +18,018,018 | 88,257,406 | +26% | +$40,000,000 | ||||||
2026-01-27 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.48 | +1,351,351 | 32,714,660 | +4% | +$1,999,999 | ||||||
2026-01-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.14 | +1,737,765 | 31,363,309 | +6% | +$1,983,334 | ||||||
| M | 2026-01-11 | YYAI | Airwa Inc. | Zhou Hongyu | Dir | P - Purchase | $1.35 | +1,109,922 | 1,601,489 | +226% | +$1,499,213 | |||||
2026-01-21 | YYAI | Airwa Inc. | Zhou Hongyu | Dir | P - Purchase | $1.37 | +4,215,000 | 5,816,489 | +263% | +$5,774,550 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |